Halozyme Therapeutics, Inc. (HALO)
108.64
+0.47
(+0.43%)
USD |
NASDAQ |
Aug 24, 16:00
108.64
0.00 (0.00%)
After-Hours: 19:20
Halozyme Therapeutics Price : 108.64 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 106.20 | 108.49 | 105.91 | 108.17 | 1.150M |
| Aug 20, 2026 | 106.41 | 107.44 | 105.20 | 106.12 | 1.578M |
| Aug 19, 2026 | 106.39 | 107.96 | 105.50 | 107.62 | 2.540M |
| Aug 18, 2026 | 102.95 | 105.11 | 102.38 | 104.89 | 1.955M |
| Aug 17, 2026 | 98.86 | 104.09 | 98.58 | 103.00 | 2.200M |
| Aug 14, 2026 | 100.35 | 100.83 | 98.13 | 98.66 | 1.659M |
| Aug 13, 2026 | 101.95 | 102.40 | 99.41 | 100.67 | 1.983M |
| Aug 12, 2026 | 102.00 | 102.58 | 100.47 | 101.79 | 3.651M |
| Aug 11, 2026 | 103.62 | 104.78 | 101.81 | 102.62 | 2.846M |
| Aug 10, 2026 | 102.67 | 104.77 | 101.11 | 102.62 | 4.935M |
| Aug 07, 2026 | 90.00 | 103.30 | 90.00 | 103.12 | 7.692M |
| Aug 06, 2026 | 84.15 | 86.00 | 82.60 | 85.76 | 2.704M |
| Aug 05, 2026 | 83.89 | 84.40 | 82.98 | 83.59 | 1.263M |
| Aug 04, 2026 | 82.78 | 83.89 | 81.75 | 83.23 | 1.575M |
| Aug 03, 2026 | 82.42 | 83.62 | 82.11 | 82.27 | 1.368M |
| Jul 31, 2026 | 83.19 | 83.27 | 81.50 | 82.54 | 1.565M |
| Jul 30, 2026 | 81.74 | 83.54 | 81.21 | 83.30 | 2.136M |
| Jul 29, 2026 | 83.08 | 83.96 | 82.60 | 83.28 | 1.634M |
| Jul 28, 2026 | 82.70 | 84.44 | 82.36 | 83.44 | 2.624M |
| Jul 27, 2026 | 82.41 | 83.50 | 81.46 | 81.48 | 1.436M |
| Jul 24, 2026 | 81.35 | 82.99 | 80.93 | 81.93 | 1.661M |
| Jul 23, 2026 | 77.43 | 81.19 | 76.82 | 80.84 | 1.751M |
| Jul 22, 2026 | 79.23 | 79.31 | 77.40 | 77.82 | 1.400M |
| Jul 21, 2026 | 76.96 | 78.64 | 76.96 | 78.60 | 1.273M |
| Jul 20, 2026 | 78.52 | 79.04 | 77.01 | 77.09 | 1.553M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 127.99 |
| Neurocrine Biosciences, Inc. | 153.04 |
| AVITA Medical, Inc. | 9.92 |
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 443.84 |
Price Related Metrics
| PE Ratio | 32.46 |
| PS Ratio | 7.903 |
| Price to Book Value | 86.31 |
| Price to Free Cash Flow | 16.31 |
| Earnings Yield | 3.08% |
| Market Cap | 12.39B |
| Operating PE Ratio | 13.92 |
| Normalized PE Ratio | 19.95 |